NVS
) closed out an 11-month legal battle on Wednesday by paying $12.9
billion to shareholders of Alcon (
ACL
) as the Basel, Switzerland-based company assumes control of nearly
three-quarters of the world's vision care market,
Forbes reports
.
Novartis, whose...
No comments:
Post a Comment